BAY 1135626, CAS 1404071-37-9

Product Description: BAY 1135626 is used to synthesize BAY 1129980, and use to anti-tumor research. BAY 1129980 is a Auristatin-based anti-C4.4A (LYPD3) antibody–agent conjugate (ADC), is used to non–small cell lung cancer (NSCLC) research[1].

Applications: Cancer-programmed cell death

Formula: C55H86N10O11

References: [1]Willuda J, et al. Preclinical Antitumor Efficacy of BAY 1129980-a Novel Auristatin-Based Anti-C4.4A (LYPD3) Antibody-Drug Conjugate for the Treatment of Non-Small Cell Lung Cancer. Mol Cancer Ther. 2017 May. 16(5):893-904.

CAS Number: 1404071-37-9

Molecular Weight: 1063.33

Compound Purity: 96.53

Research Area: Cancer

Solubility: DMSO : 100 mg/mL (ultrasonic)

Target: Drug-Linker Conjugates for ADC

• Artikelnummer: MEXHY-147281-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-147281-1
• Green Labware: Nein
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK